Cargando…

Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency

[Image: see text] Inhibition of monoglyceride lipase (MGL), also known as monoacylglycerol lipase (MAGL), has emerged as a promising approach for treating neurological diseases. To gain useful insights in the design of agents with balanced potency and reactivity, we investigated the mechanism of MGL...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvani, Francesca, Scalvini, Laura, Rivara, Silvia, Lodola, Alessio, Mor, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198976/
https://www.ncbi.nlm.nih.gov/pubmed/35580195
http://dx.doi.org/10.1021/acs.jcim.2c00140
_version_ 1784727761530650624
author Galvani, Francesca
Scalvini, Laura
Rivara, Silvia
Lodola, Alessio
Mor, Marco
author_facet Galvani, Francesca
Scalvini, Laura
Rivara, Silvia
Lodola, Alessio
Mor, Marco
author_sort Galvani, Francesca
collection PubMed
description [Image: see text] Inhibition of monoglyceride lipase (MGL), also known as monoacylglycerol lipase (MAGL), has emerged as a promising approach for treating neurological diseases. To gain useful insights in the design of agents with balanced potency and reactivity, we investigated the mechanism of MGL carbamoylation by the reference triazole urea SAR629 (IC(50) = 0.2 nM) and two recently described inhibitors featuring a pyrazole (IC(50) = 1800 nM) or a 4-cyanopyrazole (IC(50) = 8 nM) leaving group (LG), using a hybrid quantum mechanics/molecular mechanics (QM/MM) approach. Opposite to what was found for substrate 2-arachidonoyl-sn-glycerol (2-AG), covalent modification of MGL by azole ureas is controlled by LG expulsion. Simulations indicated that changes in the electronic structure of the LG greatly affect reaction energetics with triazole and 4-cyanopyrazole inhibitors following a more accessible carbamoylation path compared to the unsubstituted pyrazole derivative. The computational protocol provided reaction barriers able to discriminate between MGL inhibitors with different potencies. These results highlight how QM/MM simulations can contribute to elucidating structure–activity relationships and provide insights for the design of covalent inhibitors.
format Online
Article
Text
id pubmed-9198976
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-91989762022-06-16 Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency Galvani, Francesca Scalvini, Laura Rivara, Silvia Lodola, Alessio Mor, Marco J Chem Inf Model [Image: see text] Inhibition of monoglyceride lipase (MGL), also known as monoacylglycerol lipase (MAGL), has emerged as a promising approach for treating neurological diseases. To gain useful insights in the design of agents with balanced potency and reactivity, we investigated the mechanism of MGL carbamoylation by the reference triazole urea SAR629 (IC(50) = 0.2 nM) and two recently described inhibitors featuring a pyrazole (IC(50) = 1800 nM) or a 4-cyanopyrazole (IC(50) = 8 nM) leaving group (LG), using a hybrid quantum mechanics/molecular mechanics (QM/MM) approach. Opposite to what was found for substrate 2-arachidonoyl-sn-glycerol (2-AG), covalent modification of MGL by azole ureas is controlled by LG expulsion. Simulations indicated that changes in the electronic structure of the LG greatly affect reaction energetics with triazole and 4-cyanopyrazole inhibitors following a more accessible carbamoylation path compared to the unsubstituted pyrazole derivative. The computational protocol provided reaction barriers able to discriminate between MGL inhibitors with different potencies. These results highlight how QM/MM simulations can contribute to elucidating structure–activity relationships and provide insights for the design of covalent inhibitors. American Chemical Society 2022-05-17 2022-06-13 /pmc/articles/PMC9198976/ /pubmed/35580195 http://dx.doi.org/10.1021/acs.jcim.2c00140 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Galvani, Francesca
Scalvini, Laura
Rivara, Silvia
Lodola, Alessio
Mor, Marco
Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
title Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
title_full Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
title_fullStr Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
title_full_unstemmed Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
title_short Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
title_sort mechanistic modeling of monoglyceride lipase covalent modification elucidates the role of leaving group expulsion and discriminates inhibitors with high and low potency
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198976/
https://www.ncbi.nlm.nih.gov/pubmed/35580195
http://dx.doi.org/10.1021/acs.jcim.2c00140
work_keys_str_mv AT galvanifrancesca mechanisticmodelingofmonoglyceridelipasecovalentmodificationelucidatestheroleofleavinggroupexpulsionanddiscriminatesinhibitorswithhighandlowpotency
AT scalvinilaura mechanisticmodelingofmonoglyceridelipasecovalentmodificationelucidatestheroleofleavinggroupexpulsionanddiscriminatesinhibitorswithhighandlowpotency
AT rivarasilvia mechanisticmodelingofmonoglyceridelipasecovalentmodificationelucidatestheroleofleavinggroupexpulsionanddiscriminatesinhibitorswithhighandlowpotency
AT lodolaalessio mechanisticmodelingofmonoglyceridelipasecovalentmodificationelucidatestheroleofleavinggroupexpulsionanddiscriminatesinhibitorswithhighandlowpotency
AT mormarco mechanisticmodelingofmonoglyceridelipasecovalentmodificationelucidatestheroleofleavinggroupexpulsionanddiscriminatesinhibitorswithhighandlowpotency